| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |